{
  "id": 16745544,
  "title": "China’s Hengrui posts 89% rise in third-quarter net profit, beating estimates",
  "url": "https://urgent.news/2026/10/27/chinas-hengrui-posts-89-rise-in-third-quarter-net-profit-beating-16745544",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-27T11:30:27.000Z",
  "source": {
    "name": "SCMP Business",
    "slug": "scmp-business",
    "url": "https://www.scmp.com/business/companies/article/3372319/chinas-hengrui-posts-89-rise-third-quarter-net-profit-beating-estimates"
  },
  "original_language": "en",
  "account": null,
  "summary": "Jiangsu Hengrui Pharmaceuticals, one of China’s largest drug makers, reported a 20.55 per cent rise in third-quarter revenue to 8.95 billion yuan (US$1.34 billion), beating analyst estimates of 8.55 billion yuan amid stronger innovative drug sales. Net profit reached 2.46 billion yuan for the three months ended September 30, jumping 88.92 per cent year on year and exceeding the Bloomberg analyst…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}